Thử nghiệm STRONG-HF nhấn mạnh lợi ích của tối ưu hóa điều trị
NHỮNG KẾT QUẢ CHÍNH Hiện nay, bệnh nhân suy tim có tỷ lệ tái nhập viện và tử vong sau xuất viện cao1-4 DOWNLOAD THE REPORT...
Related Links
- ACC 2025 Spotlight: DROP-Asian ACS Interim Analysis Highlights Regional Gains in NSTEMI Care
- STRONG-HF Japan Study
- Implementing 0/1-Hour Algorithm using High-Sensitivity Cardiac Troponin in the Emergency Department
- Every Heartbeat Counts: Take Action & Make an Impact This World Heart Day
- The effectiveness of telemonitoring and integrated personalised diabetes management in people with insulin-treated type 2 diabetes mellitus
- Chinese expert consensus on the risk assessment and management of panvascular disease in patients with type 2 diabetes mellitus (2022 edition)
- STRONG-HF: Enhancing GDMT regimen in Asia
- Implementation of STRONG-HF protocol in heart failure management: an Australian perspective
- Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China
- Reshaping HF Management at NHCS
- Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients
- Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers
- 日本における糖尿病の管理 – 患者はより重要な役割を果たすことができるか？
- STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure
- Guidelines Interpretation – Guidelines for the management of chronic heart failure in dialysis patients in China
- Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment
- Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring
- Heart Failure Management in India – Overcoming Present Challenges
- STRONG-HF Trial highlighting benefits of treatment optimisation
- STRONG-HF: Implementation of GDMT Heart Failure Therapy & Post-discharge Heart Failure Management
- Uncovering the Cardio-renal Risks of Chinese T2DM patients: Back to the Future with CUHK!
- Management of Diabetes in Japan – Can Patients Play a More Significant Role?
- T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP
- Rapid algorithms for hs-cTn in ED: Boon or Bane?
- 2021 ESC Heart Failure Guidelines: What’s new?
- Heart Failure in Hong Kong- Present Challenges and Future Strategies
- Rapid Algorithms for Faster Triage of ED Patients with Suspected AMI – What Are We Waiting For?
- Digital Prediction Platforms: A catalyst towards personalized CVD prognosis
- CVD Management in T2DM – JCS and JDS Joint Consensus
- ESC Recommendation: High sensitivity troponin assay vs conventional assay
- ESC Recommendation: Rapid algorithms using hs troponin in ED
- Setting sight on breakthrough diagnostics
- Recommendations of IFCC on Natriuretic Peptide Testing
- How to Implement ESC Rapid Algorithm Successfully?
- The Changes in Rapid Algorithms for Acute Coronary Syndrome
- Sex Differences in Troponin Levels – affecting high-sensitivity cardiac troponin (hs-cTn) levels
- DAPA-HF and EMPEROR-Reduced Study Highlights
- The role of biomarkers in HF
- Digital health in HF management
- 高感度心筋トロポニン値に影響を及ぼす因子
- Summary of APSC High Sensitivity Troponin T Consensus
- APSC hs-TnT Consensus & Future Use of Biomarker in T2DM & COVID-19
- Management of Cardiovascular Risks of COVID-19 Patients
- Management of COVID-19 and the Heart, Experience from Front Line